연구동향 분석

Osteopontin expression in papillary thyroid carcinoma and its relationship with the BRAF mutation and tumor characteristics

Kyung Ho Kang 2013년

논문상세정보
    • 저자 Kyung Ho Kang
    • 제어번호 99570743
    • 학술지명 Annals of Surgical Treatment and Research(ASRT)
    • 권호사항 Vol. 84 No. 1 [ 2013 ]
    • 발행처 대한외과학회
    • 발행처 URL http://surgery.or.kr
    • 자료유형 학술저널
    • 수록면 9-17 ( 9쪽)
    • 언어 English
    • 출판년도 2013
    • 등재정보 KCI등재
    • 판매처 누리미디어
    유사주제 논문( 646)
인용/피인용
' Osteopontin expression in papillary thyroid carcinoma and its relationship with the BRAF mutation and tumor characteristics' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 외과
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
641 0

0.0%

' Osteopontin expression in papillary thyroid carcinoma and its relationship with the BRAF mutation and tumor characteristics' 의 참고문헌

  • Thyroid and parathyroid tumors, In Pathology and genetics of tumours of endocrine organs
    IARC Press : 51 ~ 56 [2004]
  • The protein kinase B/Akt signalling pathway in human malignancy
    Cell Signal 14 : 381 ~ 395 [2002]
  • The osteopontin-CD44 survival signal involves activation of the phosphatidylinositol 3-kinase/Akt signaling pathway
    J Biol Chem 276 : 46024 ~ 46030 [2001]
  • The metastasis gene osteopontin: a candidate target for cancer therapy
    Biochim Biophys Acta 1552 : 61 ~ 85 [2001]
  • The GDNF family: signalling, biological functions and therapeutic value
    Nat Rev Neurosci 3 : 383 ~ 394 [2002]
  • Surgical pathology of the thyroid
    Saunders [1990]
  • Substrate specificity of alpha(v)beta(3) integrin-mediated cell migration and phosphatidylinositol 3-kinase/AKT pathway activation
    J Biol Chem 275 : 24565 ~ 24574 [2000]
  • RET oncogene activation in papillary thyroid carcinoma
    Adv Anat Pathol 8 : 345 ~ 354 [2001]
  • Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer
    Cancer Res 62 : 3417 ~ 3427 [2002]
  • Pathogenetic mechanisms in thyroid follicular-cell neoplasia
    Nat Rev Cancer 6 : 292 ~ 306 [2006]
  • PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas
    Cell 60 : 557 ~ 563 [1990]
  • Osteopontin: role in cell signaling and cancer progression
    Trends Cell Biol 16 : 79 ~ 87 [2006]
  • Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells
    J Biol Chem 278 : 28593 ~ 28606 [2003]
  • Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness
    J Clin Endocrinol Metab 90 : 5270 ~ 5278 [2005]
  • Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experience
    Nucl Med Commun 25 : 547 ~ 552 [2004]
  • Mutations of the BRAF gene in human cancer
    Nature 417 : 949 ~ 954 [2002]
  • Mutations of the BRAF Gene in Papillary Thyroid Carcinoma in a Korean Population
    Yonsei Medical Journal 45 (5) : 818 ~ 821 [2004]
  • Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma: an unusually high prevalence of ras mutations
    Am J Clin Pathol 120 : 71 ~ 77 [2003]
  • Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis
    Oncogene 24 : 6646 ~ 6656 [2005]
  • High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma
    Cancer Res 63 : 1454 ~ 1457 [2003]
  • Follicular variant of papillary thyroid carcinoma: a comparative study of histopathologic features and cytology results in 141 patients
    Endocr Pract 7 : 79 ~ 84 [2001]
  • Follicular variant of papillary thyroid carcinoma. A clinicopathologic study
    Cancer 73 : 424 ~ 431 [1994]
  • Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors
    Proc Natl Acad Sci U S A 104 : 9001 ~ 9006 [2007]
  • BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas
    J Clin Endocrinol Metab 89 : 2414 ~ 2420 [2004]
  • BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas
    J Clin Endocrinol Metab 88 : 5399 ~ 5404 [2003]
  • BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer
    J Clin Endocrinol Metab 90 : 6373 ~ 6379 [2005]
  • BRAF mutation in papillary thyroid carcinoma
    J Natl Cancer Inst 95 : 625 ~ 627 [2003]
  • Autocrine stimulation by osteopontin plays a pivotal role in the expression of the mitogenic and invasive phenotype of RET/PTC-transformed thyroid cells
    Oncogene 23 : 2188 ~ 2196 [2004]
  • Activation of a novel human transforming gene, ret, by DNA rearrangement
    Cell 42 : 581 ~ 588 [1985]